Presentation slides and video from the 2021-2022 Advances in Cancer Immunotherapy™ Series - A Focus on Hematologic Malignancies held virtually on February 2, 2022 are available here.
Program Organizers
Program Summary
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are half-day innovative programs will have the opportunity for in-depth training in immunotherapy treatment for a variety of topics from leaders in this specific field. The ACI program also featured a discussion of closed cases submitted from attendees to hear guidance and insights from expert faculty.
Program Learning Objectives
Please note on-demand recordings are not available for continuing education credits.#AdvancesinCancerImmunotherapy(ACI)#2022#HematologicMalignancies#PresentationSlides#Video
Meeting: 2021-2022 Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies; Presenter: Charalambos (Babis) Andreadis, MD, MSCE – University of California San Francisco; Naval Daver, MD – The University of Texas MD Anderson Cancer Center; Aaron Logan, MD, PhD – University of California San Francisco; Nina Shah, MD – University of California San Francisco; Samantha Shenoy, NP – UCSF Medical Center; Surbhi Sidana, MD – Stanford University; Michael Spinner, MD – Stanford University; Date: February 2, 2022;00:29:54
Meeting: 2021-2022 Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies; Presenter: Charalambos (Babis) Andreadis, MD, MSCE – University of California San Francisco; Date: February 2, 2022;00:25:01
Meeting: 2021-2022 Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies; Presenter: Nina Shah, MD – University of California San Francisco; Date: February 2, 2022;00:24:40
Meeting: 2021-2022 Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies; Presenter: Surbhi Sidana, MD – Stanford University; Date: February 2, 2022;00:23:18
Meeting: 2021-2022 Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies; Presenter: Samantha Shenoy, NP – UCSF Medical Center; Date: February 2, 2022;00:24:38
Meeting: 2021-2022 Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies; Presenter: Michael Spinner, MD – Stanford University; Date: February 2, 2022;00:21:25
Meeting: 2021-2022 Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies; Presenter: Naval Daver, MD – The University of Texas MD Anderson Cancer Center; Date: February 2, 2022;00:26:12
Meeting: 2021-2022 Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies; Presenter: Aaron Logan, MD, PhD – University of California San Francisco; Date: February 2, 2022;00:28:37
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us